Overview

EQx Fund operates an evergreen Angel Fund focused on diversified early stage investments in extraordinary Founders

Emotional Quotient (EQ): the ability to understand, cooperate with and motivate others

Leadership and Passion is key
Opportunistic/Industry-Agnostic
Industry Disruptors/High growth opportunities

About Us

Ziad H. Moukheiber serves as Managing Partner for the EQx Fund. He is the CEO of the renowkned Boston Harbor Angels organization, which has boasted a series of successful exits and is recognized as one of the top Angel Groups in the country. Ziad maintains an Angel portfolio of his own, concentrated in early stage technology and life science opportunities. Prior to his current roles, he founded and ran an IT consulting firm, Silversword, which was acquired by NSK Inc. in 2015.

Jason Kraus serves as a partner in the EQx Fund, specializing in deal flow. He has experience in the venture arm of a private family office and as a member for the Boston Harbor Angels. Jason founded a startup advisory firm, Prepare 4 VC, to coach entrepreneurs through the fundraising process and create more powerful pitches. He is also a co-founder of commercial real estate and early stage investment firm Equity Venture Partners

Contact

Our content

Ziad Moukheiber of Boston Harbor Angels & EQx Fund (East Coast), and Faz Bashi (West Coast) of Life Science Angels, have a good time chatting about Angel Investing, Entrepreneurship, Restaurants, Politics with good friends and always with great humor and lots of laughter ! Join us https://open.spotify.com/show/7omFOaEhHRg4nLMAta2ixO
This book defies the one-size fits all startup mentality with stories from proven leaders on how they built their businesses in ways that defied the norm, providing lessons for our readers as they grow and scale their own ventures. Jason Kraus wrote is passionate about helping entrepreneurs succeed and has built a career around filling in the gaps in the startup ecosystem to build the next wave of innovation. The book will publish in October, 2019. https://www.indiegogo.com/projects/venture-forward-lessons-from-leaders-jason-kraus#/

EQx Portfolio of Founders

David Friend is a serial entrepreneur with 6 exits under his belt to date, including Carbonite, a data storage giant that went public in 2011. His current venture Wasabi, is disrupting the cloud storage market with a platform that is enterprise class, tier-free, instantly available and allows you to store an infinite amount of data affordably.
Dr. Alex Mehr is the founder of online dating company Zoosk which amassed over $800M in revenue during his tenure as CEO. He got to where he is by a constant desire for learning staying on pace with the average CEO who reads 60 books per year. His current venture, Mentorbox makes this constant learning accessible to the masses through curated book boxes and online courses with video interviews and lessons from authors.
Sean Ainsworth was the founder of RetroSense, a gene therapy company that was acquired by Allergen. He joined as CEO of his new venture Immusoft, which is creating a novel system called Immune System Programming (ISP) that programs B cells to create protein therapeutics.
Bill Korinek served as the Head of Worldwide R&D operations for Pfizer before launching his current venture Astrocyte Pharmaceuticals. Astrocyte is developing a breakthrough therapeutic agents for treating brain injury patients
Laurel Taylor served as Head of Industry for Google before attending an MBA program at MIT. She had a great job and a perfect credit score but the student loan options were all still very high. She dug into the problem and launched FutureFuel to combat the student debt crisis through an employee benefits fintech platform to alleviate student debt.
Frank Makrides served as the Lead Principal Engineer at BAE system before he and his team came together to form Tunnel with a distributed ledger technology (DLT) that provides real-tie global cross-border payments and enterprise-grade security
Melissa Fensterstock has a background in medtech at companies working in regulatory affairs for companies like Stryker. She launched a consumer beauty product leading it into 600 retailers before launching her current startup Landsdowne Labs. The company is developed a coating to prevent chemical effects from battery ingestion, and was spun out of the prestigious Robert Langer Lab at MIT and Jeff Karp Lab at Harvard.
Dalton Shaull is a Forbes 30 under 30 recipient and founded OmniLife after an experimental nerve transplant helped him recover from a motorcycle accident. OmniLife streamlines the organ donation process for transplant centers, matching organs with the right recipient and center as soon as they come in, saving lives with an Ai-driven HiPAA compliant chat system.
Hasan Celiker earned a doctorate in microbial ecology and evolution from MIT and served as a consultant for various biotech startups before launching Xeno Biosciences. Xeno is creating a pharmaceutical application to mimic the effects of gastric bypass surgery.
Todd Zion previously founded SmartCells an injectable formulation to treat diabetes, and sold the company to Merck for $500M. The team is back together under Akston Biosciences, developing biologic therapeutics to prevent Type I diabetes.
Tom Schultz has founded and guided multiple companies from concept to exit, including IPO. His previous venture PanTheryx saved lives in third world countries around the world treating Pediatric Diarhea. His new venture Anubis Bio applies the proven methodology to the pet industry with its first product DoggyStat.
Lynn Browne and Mollie Kehoe are co-founders of BrandVerge, a marketplace that streamlines the way advertisers connect with their favorite media channels. Lynn’s background as a media buyer and Mollie’s expertise in media sales create the perfect duo.
Sam Rasty has 20+ years experience in biopharma leadership including serving as the Chief Operating Officer for Homology medicines. His current venture Platelet Biogenesis developed a technology to create blood platelets by mimicking conditions inside bone marrow.